Expression of chemokines and adhesion molecules in human coronary artery endothelial cells infected with Chlamydia (Chlamydophila) pneumoniae

被引:28
作者
Hogdahl, M. [2 ]
Soderlund, G. [3 ]
Kihlstrom, E. [1 ,2 ]
机构
[1] Linkoping Univ, Dept Clin & Expt Med, Fac Hlth Sci, Div Clin Microbiol, S-58185 Linkoping, Sweden
[2] Linkoping Univ Hosp, Dept Clin Microbiol, S-58185 Linkoping, Sweden
[3] Linkoping Univ Hosp, Dept Oncol, S-58185 Linkoping, Sweden
基金
英国医学研究理事会;
关键词
Coronary artery inflammation; C; pneumoniae; chemokines;
D O I
10.1111/j.1600-0463.2008.01145.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chlamydia pneumoniae has during recent years been associated with cardiovascular disease and atherosclerosis. Chemokines, leukocyte adhesion proteins and metalloproteinases are significant for chemotaxis and attachment of leukocytes to vessel walls, and for stability of atherosclerotic plaques. To determine the ability of C. pneumoniae to elicit inflammation in a relevant target host cell, we infected human coronary artery endothelial cells (HCAEC) with a clinical isolate of C. pneumoniae. Extracellular release of five chemokines, two adhesion proteins and a metalloproteinase was measured at different time points after infection using a cytometric bead assay and ELISA. Secretion of IL-8, MCP-1, MIG, IP-10 and ICAM-1 was significantly increased 48 h after C. pneumoniae infection of HCAEC in comparison with uninfected controls. Release of RANTES occurred already 6 h after infection. C. pneumoniae did not elicit release of E-selectin or MMP-1. We conclude that C. pneumoniae induces expression of proinflammatory components in HCAEC, which would promote migration of leukocytes towards endothelial cells. This suggests that C. pneumoniae initiates and propagates vascular inflammation in ways that contribute to coronary artery disease.
引用
收藏
页码:1082 / 1088
页数:7
相关论文
共 35 条
  • [1] Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques
    Arno, G
    Kaski, JC
    Smith, DA
    Akiyu, JP
    Hughes, SE
    Baboonian, C
    [J]. HEART, 2005, 91 (04) : 521 - 525
  • [2] Chlamydia pneumoniae and atherosclerosis
    Belland, RJ
    Ouellette, SP
    Gieffers, J
    Byrne, GI
    [J]. CELLULAR MICROBIOLOGY, 2004, 6 (02) : 117 - 127
  • [3] Adhesion molecules and atherosclerosis
    Blankenberg, S
    Barbaux, S
    Tiret, L
    [J]. ATHEROSCLEROSIS, 2003, 170 (02) : 191 - 203
  • [4] Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome
    Cannon, CP
    Braunwald, E
    McCabe, CH
    Grayston, JT
    Muhlestein, B
    Giugliano, RP
    Cairns, R
    Skene, AM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (16) : 1646 - 1654
  • [5] Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-κB and induces tissue factor and PAI-1 expression -: A potential link to accelerated arteriosclerosis
    Dechend, R
    Maass, M
    Gieffers, J
    Dietz, R
    Scheidereit, C
    Leutz, A
    Gulba, DC
    [J]. CIRCULATION, 1999, 100 (13) : 1369 - 1373
  • [6] Endothelial Chlamydia pneumoniae infection promotes oxidation of LDL
    Dittrich, R
    Dragonas, C
    Mueller, A
    Maltaris, T
    Rupp, J
    Beckmann, MW
    Maass, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 319 (02) : 501 - 505
  • [7] Fryer RH, 1997, J INVEST MED, V45, P168
  • [8] Growth in vascular cells and cytokine production by Chlamydia pneumoniae
    Gaydos, CA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 181 : S473 - S478
  • [9] Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature
    Gieffers, J
    van Zandbergen, G
    Rupp, J
    Sayk, F
    Krüger, S
    Ehlers, S
    Solbach, W
    Maass, M
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (04) : 506 - 510
  • [10] First-choice antibiotics at subinhibitory concentrations induce persistence of Chlamydia pneumoniae
    Gieffers, J
    Rupp, J
    Gebert, A
    Solbach, W
    Klinger, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (04) : 1402 - 1405